EUVIMEDEUVIMED entdecken
Crossref

A Novel UPLC–MS/MS Method for Determining Tegoprazan in Rat Plasma: An Application in a Rat Pharmacokinetic Study

Mengjie Xu, Yize Cai, Yu Wang, Manjie Lin, Qinghua Weng iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Mengjie Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Center, Wenzhou People's Hospital, Wenzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tegoprazan (TEG) is a commonly used drug in the treatment of gastroesophageal reflux disease. This work aimed to develop and validate an ultra‐high‐performance liquid chromatography–tandem mass Spectrometry (UPLC–MS/MS) method to determine the levels of TEG in rat plasma and to apply it for a rat pharmacokinetic study. Electrospray ionization source (ESI) positive and multiple reaction monitoring (MRM) mode were selected. The internal standard revaprazan (REV) and TEG were analyzed separately on a Waters ACQUITY UPLC BEH column. Gradient elution with a flow rate of 0.5 mL/min was used. Accuracy and precision were from −8.5% to 12.2%. Linearity was from 2 to 1000 ng/mL. IS‐normalized recovery ranged from 109.3% to 113.6%. IS‐normalized matrix effect was from 99.0% to 102.8%. The coefficient of variation of matrix effect was less than 10%. Dilution integrity showed that a tenfold dilution also met the guidelines. In the rat pharmacokinetic study, AUC (0 − ∞) and C max of TEG were 9129.6 ± 1823.3 μg/L*h and 2513.2 ± 707.0 ng/mL, respectively. T max and T 1/2 were 1.8 ± 1.1 h and 1.6 ± 0.8 h, respectively. We finally established a rapid and robust UPLC–MS/MS quantitative analysis of TEG in rat plasma. Rat pharmacokinetics indicated that TEG was absorbed quickly and fast reached the maximum concentration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAnimalsChromatography, High Pressure LiquidRatsMaleReproducibility of ResultsRats, Sprague-DawleyLinear ModelsSensitivity and SpecificityLimit of DetectionDrug StabilityLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

UPLC–MS/MSpharmacokineticsrattegoprazan

Autor:innen und Institutionen

  • Precision Medicine Center, Wenzhou People's Hospital, Wenzhou, China.
  • First Clinical College of Wenzhou Medical University, Wenzhou, China.
  • School of Basic Medicine, Wenzhou Medical University, Wenzhou, China.
  • Department of Pharmacy, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, China.
  • Department of Pharmacy, Wenzhou People's Hospital, Wenzhou, China.

ORCID-Profile: Qinghua Weng

Förderung

  • Wenzhou Municipal Science and Technology Bureau

Zitieren

APA

Xu, M., Cai, Y., Wang, Y., Lin, M., & Weng, Q. (2025). A Novel UPLC–MS/MS Method for Determining Tegoprazan in Rat Plasma: An Application in a Rat Pharmacokinetic Study. Biomedical Chromatography. https://doi.org/10.1002/bmc.70264

Vancouver

Xu M, Cai Y, Wang Y, Lin M, Weng Q. A Novel UPLC–MS/MS Method for Determining Tegoprazan in Rat Plasma: An Application in a Rat Pharmacokinetic Study. Biomedical Chromatography. 2025. doi:10.1002/bmc.70264

BibTeX
@article{Xu2025,
  author = {Xu, Mengjie and Cai, Yize and Wang, Yu and Lin, Manjie and Weng, Qinghua},
  title = {A Novel UPLC–MS/MS Method for Determining Tegoprazan in Rat Plasma: An Application in a Rat Pharmacokinetic Study},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70264}
}
Kostenlos starten →